Expertise in
3
conditions

Milada Zemanova

Prague, PR, CZ 
Expertise in
3
conditions
Prague, PR, CZ 

Overview

Milada Zemanova practices practicing medicine in Prague, Czech Republic.

Ms. Zemanova is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, and Nephrectomy.

She is actively involved in clinical research, co-authoring 61 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Prague, PR, Czech Republic
Other Locations
Pilsen, PL, Czech Republic
Brno, JM 62500, Czech Republic
Ceske Budejovice, JC 37005, Czech Republic

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
Enrollment Status: Terminated
Publish Date: February 02, 2024
Intervention Type: Drug, Biological
Study Drugs: OSE2101, Docetaxel, Pemetrexed
Study Phase: Phase 3

61 Total Publications

Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.
Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2026

Frequently Asked Questions about Milada Zemanova

Is Milada Zemanova a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Milada Zemanova is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Milada Zemanova participate in research or clinical trials?

Yes. Milada Zemanova has published 61 articles and abstracts on conditions like Lung Cancer. You can view a list of Milada Zemanova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Zemanova's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile